Welcome to this edition of e-Pharmalink newsletter where we spotlight EPN’s ongoing efforts to improve access to quality essential medicines and strengthen pharmaceutical supply chains in the faith-based health system.
In this issue, we explore…
- Closing the Gaps: Unlocking the Potential of the EPN DSO Maturity Tool
- How EPN’s Availability Tool Enhances Stock Visibility
- What EPN’s Market Study Reveals about MNCH Access: Insights from the EPN Market Assessment and Procurement Analysis
Closing the Gaps: Unlocking the Potential of the EPN DSO Maturity Tool
From Shortages to Solutions: How EPN’s Availability Tool Enhances Stock Visibility
When health facilities run out of essential medicines, patient care can suffer, but stock management can be accurate and informedinstead. The EPN Availability Monitoring Tool (AMT), a practical solution designed to improve stock visibility, prevent shortages, and reduce waste in resource-limited settings. By tracking key data on essential medicines, the tool empowers healthcare workers to make informed decisions, improve forecasting, and streamline supply chain planning across faith-based health systems.
Breaking Barriers to Lifesaving Care: What EPN’s Market Study Reveals about MNCH Access
Access to lifesaving maternal and child health products shouldn’t depend on geography or market inefficiencies, yet for many in low-resources settings, it still does. A recent EPN market study, under an EPN project explored how pooled procurement, quality assurance, and strategic supplier engagement is reshaping access to 12 priority Maternal and Child Health (MNCH) products. By identifying pricing gaps, regulatory hurdles, and supply chain inefficiencies, the study offers a clear roadmap for improving affordability, availability, and equity in faith-based healthcare delivery.